Stocks Result Analysis for Industry - Biotechnology for Q1 FY25-26 ending Jun 30, 2025

Analysis of which stocks have performed the best and worst in Industry - Biotechnology for Q1 FY25-26 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current quarter are considered.

Choose Stock universe, Portfolio or index

Note: Industry-level growth metrics have been calculated by totaling the numbers of all companies in that industry, to get an average.

4
POSITIVE PROFIT GROWTH
3
NEGATIVE PROFIT GROWTH
0
NEUTRAL PROFIT GROWTH
13.7 %
TOTAL REVENUE GROWTH
-49.3 %
TOTAL EBIDT GROWTH
15.2 %
TOTAL OPER. PROFIT GROWTH
 Positive  Negative  Pending
Stock Market Capitalization Operating Revenue Qtr Revenue Growth Qtr YoY % Revenue Surprise Qtr % Net Profit Qtr Net Profit Qtr Growth YoY % Net Profit Surprise Qtr % Operating Profit Qtr Operating Profit Growth Qtr YoY % EBITDA Qtr EBITDA Qtr growth YoY % Operating Profit Margin Qtr % Operating Profit Qtr Margin% YoY Change Last Result Updated
Alpa Laboratories 203.08 - - 13-Aug-2025
Biocon 48164.11 -1.03 -69.34 07-Aug-2025
Vivo Bio Tech 60.39 - - 12-Aug-2025
Genomic Valley Biotech 12.31 - - 08-Aug-2025
Shree Ganesh Bio-Tech 31.49 - - 25-Jul-2025
Advanced Enzyme 3434.19 - - 02-Aug-2025
Concord Biotech 17090.10 -13.84 -32.37 08-Aug-2025